Lupus

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Register here to gain access to SAGE's 500+ Journals Online

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bengtsson, A.
Right arrow Articles by Sturfelt, G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bengtsson, A.
Right arrow Articles by Sturfelt, G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Lupus, Vol. 5, No. 6, 598-601 (1996)
DOI: 10.1177/096120339600500607

Factor V:Q506 mutation and anticardiolipin antibodies in systemic lupus erythematosus

A. Bengtsson

Department of Rheumatology, Lund University Hospital

B. Zöller

Department of Clinical Chemistry, Malmö General Hospital, S-205 02 Malmö, Sweden

PG de Frutos

Department of Clinical Chemistry, Malmö General Hospital, S-205 02 Malmö, Sweden

B. Dahlbäck

Department of Clinical Chemistry, Malmö General Hospital, S-205 02 Malmö, Sweden

G. Sturfelt

Department of Rheumatology, Lund University Hospital

Inherited resistance to activated protein C (APC resistance) is an important risk factor of venous thrombosis. It is caused by a point mutation in the gene coding for coagulation factor V, called FV:Q506. Arterio-venous thrombosis is a common and serious medical problem in patients with systemic lupus erythematosus (SLE). We studied the prevalence of the factor V mutation associated with APC resistance and IgG anticardiolipin antibodies (aCLs) in an epidemiological cohort of 78 Swedish SLE patients, to determine their roles as risk factors for thrombosis. In addition, a detailed evaluation of the clinical manifestations in these patients was performed. Totally, 19 (24%) of the 78 SLE patients had thrombosis, 11 (14%) had venous thrombosis and 8 (10%) had a cerebral infarction caused by occlusion of cerebral vessels. Twenty-six (33%) SLE patients were aCL positive and 8 (10%) were heterozygous for the factor V mutation. Only one of the patients with venous thrombosis and one of the patients with cerebral thrombosis had the FV:Q506 mutation, whereas 3 patients with venous thrombosis and 5 patients with cerebral infarction were aCL positive. Eleven of 19 patients with heart valve disease were aCL positive, a statistically significant association (P = 0.01). In conclusion, we found no statistically significant association between venous thrombosis and FV:Q506 mutation or venous thrombosis and aCL positivity. There was, however, an association between heart valve disease and aCL positivity.

Key Words: factor V • SLE • APC-resistance • thrombosis • aCL


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 LupusHome page
F-J Munoz-Rodriguez, J-C Reverter, J Font, D Tassies, G Espinosa, R Cervera, F Carmona, J Balasch, M Ingelmo, and A Ordinas
Clinical significance of acquired activated protein C resistance in patients with systemic lupus erythematosus
Lupus, November 1, 2002; 11(11): 730 - 735.
[Abstract] [PDF]

Home page
 StrokeHome page
P. Ludemann, D. G. Nabavi, R. Junker, E. Wolff, K. Papke, H. Buchner, G. Assmann, and E. B. Ringelstein
Factor V Leiden Mutation Is a Risk Factor for Cerebral Venous Thrombosis : A Case-Control Study of 55 Patients
Stroke, December 1, 1998; 29(12): 2507 - 2510.
[Abstract] [Full Text] [PDF]

Home page
 LupusHome page
M. Lockshin
Editorial: Why do patients with antiphospholipid antibody clot?
Lupus, January 1, 1997; 6(4): 351 - 352.
[PDF]